Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Stock Options Activity

The following summarizes the Company’s stock option activity for the years ended December 31, 2021 and 2020:

	Options Outstanding
	Number of Shares			Weighted Average Exercise Price		Weighted- Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding – December 31, 2019		7,738,866		$	0.49		7.36	$	5,848
Granted		1,993,969		1.24
Exercised		(318,564	)		0.40
Cancelled		(1,531,184	)	0.93
Outstanding – December 31, 2020		7,883,087		0.59			6.83	$	5,058
Granted		3,761,109		7.93
Exercised		(158,129	)	0.16
Cancelled		(1,458,973	)	1.11
Outstanding – December 31, 2021		10,027,094		$	3.28	7.23		$	67,173
Exercisable – December 31, 2020		5,063,856		$	0.33	5.78		$	4,592
Exercisable – December 31, 2021		5,176,464		$	0.46	5.33		$	49,268

Schedule of Quantitative Information Regarding Assumptions Used in Binomial Lattice Model

The Company calculated the fair value of option grants on the respective dates of grant using the following weighted average assumptions:

	Years ended
	December 31,			December 31,
	2021			2020
Options
Risk-free interest rate		1.19	%		0.51	%
Expected term (in years)	6.08				6.06
Expected dividend yield		—	%		—	%
Expected volatility		66.56	%		64.98	%

Summary of RSUs and RSAs Activity

The following summarizes the Company’s employee RSU activity for the years ended December 31, 2021 and 2020:

	Restricted Stock Units Outstanding
	Number of Shares			Weighted- Average Grant-Date Fair Value(1)
Outstanding – December 31, 2019		1,454,642		$	8.78
Granted		384,692		3.25
Cancelled		(938,117	)	6.51
Outstanding – December 31, 2020		901,217		$	8.78
Granted		932,123		7.93
Released		(28,982	)	8.78
Cancelled		(6,884	)	8.78
Outstanding – December 31, 2021		1,797,474		$	8.34

(1) Weighted average grant-date fair values have been updated to reflect the impact of the modification to the RSUs discussed below.

The following summarizes the Company’s employee RSAs activity for the year ended December 31, 2021:

	Restricted Stock Awards Outstanding
	Number of Shares		Weighted-Average Grant-Date Fair Value
Outstanding – December 31, 2020		—	$	—
Granted		5,129,222		8.78
Outstanding – December 31, 2021		5,129,222	$	8.78

Schedule of Stock Based Compensation Expense

The Company recognized stock-based compensation expense in the consolidated statement of operations and comprehensive loss as follows:

	December 31,		December 31,
(In thousands)	2021		2020
Cost of revenue	$	92	$	109
Research and development		446		249
Sales and marketing		814		45
General and administrative		41,766		1,888
Total stock-based compensation expense	$	43,118	$	2,291